TCON
TRACON Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website raconpharma.com
- Employees(FY) 18
- ISIN US89237H3084
Performance
-21.86%
1W
-16.37%
1M
-61.72%
3M
-55.28%
6M
-59.17%
YTD
-89.02%
1Y
Profile
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of refractory soft tissue sarcoma; and YH001, an investigational humanized cytotoxic T-lymphocyte-associated protein 4 IgG1 monoclonal antibody that is in Phase I clinical trial for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors and lymphomas, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. In addition, it is developing bispecific antibodies, which are in preclinical stage. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309 and bispecific antibodies; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.
Technical Analysis of TCON 2024-05-10
Overview:
In analyzing the technical indicators for TCON over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-14 18:53
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2024-05-14 15:10
- 2024-05-14 08:56
TCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024(Investorplace)
- 2024-05-14 04:10
Tracon: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-14 04:01
- 2024-05-07 04:01
- 2024-04-09 18:30
- 2024-04-07 21:10
TRACON Pharmaceuticals Announces Reverse Stock Split(Globenewswire)
- 2024-04-02 20:00
- 2024-03-06 21:03
- 2024-03-05 03:29
Tracon: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-05 03:02
- 2024-02-28 03:02
- 2023-12-19 19:00
- 2023-11-20 18:55
Why Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?(Investorplace)
- 2023-11-20 18:32
- 2023-11-19 19:00
- 2023-11-12 20:29
Why Is Tracon Pharmaceuticals (TCON) Stock Down 22% Today?(Investorplace)
- 2023-11-11 19:47
- 2023-11-09 18:45
Why Is Tracon Pharmaceuticals (TCON) Stock Up 130% Today?(Investorplace)
- 2023-11-09 03:58
Tracon: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-09 03:02
- 2023-10-31 04:02
- 2023-09-17 20:00
- 2023-09-05 04:02
- 2023-08-24 19:20
- 2023-08-14 20:43
Q2 2023 TRACON Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2023-08-14 07:00
Tracon: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-08-14 04:02
- 2023-08-02 04:05
Page 1 of 4
previousnext